These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4191771)

  • 1. [Etiology and treatment of Graves' disease (some problems)].
    Werner SC
    Nord Med; 1968 Dec; 80(49):1645-50. PubMed ID: 4191771
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of the active severe eye changes of Graves' disease.
    Werner SC
    Trans Am Acad Ophthalmol Otolaryngol; 1967; 71(4):631-7. PubMed ID: 6072401
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunological aspects of Graves' disease and importance of thyroid stimulating immunoglobulins.
    Bech K
    Acta Endocrinol Suppl (Copenh); 1983; 254():3-38. PubMed ID: 6191508
    [No Abstract]   [Full Text] [Related]  

  • 4. An informative case of Graves' disease with implications for schizophrenia.
    Adams DD; Knight JG; Manning P; Smith G
    J Clin Lab Immunol; 2004-2005; 53():13-25. PubMed ID: 16805322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Graves' disease].
    Endo T
    Nihon Rinsho; 2006 May; Suppl 1():235-8. PubMed ID: 16776134
    [No Abstract]   [Full Text] [Related]  

  • 6. The choices of therapy in Graves' disease.
    Stanbury JB
    Med Times; 1970 Nov; 98(11):105-20. PubMed ID: 4097048
    [No Abstract]   [Full Text] [Related]  

  • 7. LATS and Graves' disease.
    Soloman DH; Chopra IJ
    Calif Med; 1970 Aug; 113(2):50-5. PubMed ID: 5538194
    [No Abstract]   [Full Text] [Related]  

  • 8. Thyroid stimulating immunoglobulin in Graves' disease.
    Luttrell BM; Hales IB
    Aust N Z J Med; 1981 Jun; 11(3):293-8. PubMed ID: 6170289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of antithyroid therapy on the long-acting thyroid stimulator and the antithyroglobulin antibodies.
    Pinchera A; Liberti P; Martino E; Fenzi GF; Grasso L; Rovis L; Baschieri L; Doria G
    J Clin Endocrinol Metab; 1969 Feb; 29(2):231-8. PubMed ID: 4179303
    [No Abstract]   [Full Text] [Related]  

  • 10. Autoimmune thyroid disease: an integrated concept of Graves' and Hashimoto's diseases.
    Selenkow HA; Wyman P; Allweiss P
    Compr Ther; 1984 Apr; 10(4):48-56. PubMed ID: 6373115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy.
    Antonelli A; Fallahi P; Rotondi M; Ferrari SM; Serio M; Miccoli P
    Br J Surg; 2006 Oct; 93(10):1226-31. PubMed ID: 16838393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long acting thyroid stimulating immunoglobulin in pathogenesis of diffused thyrotoxicosis (author's transl)].
    Zao WS; Wang SZ
    Sheng Li Ke Xue Jin Zhan; 1981 Feb; 12(2):119-25. PubMed ID: 6895561
    [No Abstract]   [Full Text] [Related]  

  • 13. Antithyroid drug-induced immunomodulation in Graves' disease patients.
    Lechpammer M; Lukac J; Lechpammer S; Kusić Z
    Acta Med Croatica; 2002; 56(1):21-6. PubMed ID: 12455450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational management of thyroid auto-immune disease.
    Adams DD
    N Z Med J; 1974 Dec; 80(529):486-9. PubMed ID: 4141486
    [No Abstract]   [Full Text] [Related]  

  • 15. [Managing Graves' orbitopathy].
    Kahaly GJ
    Z Arztl Fortbild Qualitatssich; 2004 May; 98 Suppl 5():63-6. PubMed ID: 15255315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current physiopathology of Basedow's disease].
    Saltiel H; Schaison G; Valcke JC
    Presse Med (1893); 1969 Oct; 77(45):1605-8. PubMed ID: 4189478
    [No Abstract]   [Full Text] [Related]  

  • 17. [Etiology of Basedow's disease].
    Miyai K
    Nihon Rinsho; 1971 May; 29(5):1286-93. PubMed ID: 4996745
    [No Abstract]   [Full Text] [Related]  

  • 18. [Basedow's disease].
    Scheidegger K
    Schweiz Rundsch Med Prax; 1993 Aug; 82(32):840-4. PubMed ID: 7690495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralization of the long-acting thyroid stimulator by thyroid subcellular fractions.
    Berumen FO; Lobsenz IL; Utiger RD
    J Lab Clin Med; 1967 Oct; 70(4):640-9. PubMed ID: 6072404
    [No Abstract]   [Full Text] [Related]  

  • 20. TSH binding by globulins from patients with Graves' disease.
    Bíró J
    Endocrinol Exp; 1981; 15(2):145-53. PubMed ID: 6114853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.